Analyst Coverage Updates – BioPharmX Corporation
Post# of 223
Recently stock market analysts have updated their consensus ratings on shares of BioPharmX Corporation (BPMX). The latest broker reports which are currently outstanding on Wednesday 27th January state 0 analysts have a rating of “strong buy”, 2 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.
Most recent broker ratings
09/04/2015 – Sterne Agee began new coverage on BioPharmX Corporation giving the company a “buy” rating. They now have a USD 3.5 price target on the stock.
09/03/2015 – CRT Capital began new coverage on BioPharmX Corporation giving the company a “buy” rating.
BioPharmX Corporation has a 50 day moving average of 1.54 and a 200 day moving average of 1.51. The stock’s market capitalization is 32.69M, it has a 52-week low of 0.91 and a 52-week high of 4.50.
The share price of the company (BPMX) was up +0.65%, with a high of 1.58during the day and the volume of BioPharmX Corporation shares traded was 5075.
Published On: Wed, Jan 27th, 2016